Circadin® 2mg prolonged-release melatonin formulation, approved for use (up to 13 weeks) in treatment of primary insomnia characterized by poor quality of sleep in patients aged 55 years or over.

For more details and precautions Product information leaflet


Slenyto® is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or Smith-Magenis Syndrome (SMS), where sleep hygiene measures have been insufficient.

For more details and precautions Product information leaflet

*Presented information is not intended to replace a consultation with a qualified physician. Do not rely on the content and presented information for the purpose of receiving or providing medical care
*Before use, consult the doctor / product information leaflet


Neu-P12 is a multi-facetted new chemical entity with analgesic potential.
Its mechanism of action involves inhibition of human Nav1.7 sodium channels and TRPV1 non-selective cation channels that are widely expressed in skin tissues, and peripheral sensory nerve fibers. Neu-P12 does not interact with COX 1 or 2 or opioid receptors, suggesting a selective mode of action. It demonstrates a good potential for the treatment of inflammatory and pain in three different and relevant animal pain models.
Neu-P12 is intended as a therapy for neuropathic pain and is currently in Phase I at First in Human stage.

Products in Preclinical Phase


Neu-240 is a potent and selective uncompetitive NMDA receptor modulator aimed at improving motor control. Neu-240 is a derivative of Neu-120, intended for use as adjunct therapy to levodopa in patients with Parkinson’s disease and is currently at the preclinical stage.

  • Text size: A A A
  • Circadin
  • Recent news

    • We are delighted to invite ESCAP 2022 attendees to participate in our satellite symposium “Screen, Evaluate and Treat Insomnia in Children with ASD” on Monday, June 20th at 12:30.
    • We are excited and inspired to meet our partners F2F again!
    • Slenyto is now available in Spain!
  • Partners